title: Non-invasive methods for liver fibrosis prediction in hemochromatosis: One step beyond.
abstract: Advances in recent years in the understanding of, and the genetic diagnosis of hereditary hemochromatosis (HH) have changed the approach to iron overload hereditary diseases. The ability to use a radiologic tool (MRI) that accurately provides liver iron concentration determination, and the presence of non-invasive serologic markers for fibrosis prediction (serum ferritin, platelet count, transaminases, etc), have diminished the need for liver biopsy for diagnosis and prognosis of this disease. Consequently, the role of liver biopsy in iron metabolism disorders is changing. Furthermore, the irruption of transient elastography to assess liver stiffness, and, more recently, the ability to determine liver fibrosis by means of MRI elastography will change this role even more, with a potential drastic decline in hepatic biopsies in years to come. This review will provide a brief summary of the different non-invasive methods available nowadays for diagnosis and prognosis in HH, and point out potential new techniques that could come about in the next years for fibrosis prediction, thus avoiding the need for liver biopsy in a greater number of patients. It is possible that liver biopsy will remain useful for the diagnosis of associated diseases, where other non-invasive means are not possible, or for those rare cases displaying discrepancies between radiological and biochemical markers.
authors.affiliation: Agustin Castiella, Eva Zapata, Gastroenterology Service, Mendaro Hospital, Mendaro 20850, Spain.
authors.forename: Agustin
authors.initials: A
authors.lastname: Castiella
authors.forename: Eva
authors.initials: E
authors.lastname: Zapata
authors.forename: José M
authors.initials: JM
authors.lastname: Alústiza